DTC
AVTX icon

Deep Track Capital’s Avalo Therapeutics AVTX Stock Holding History

Deep Track Capital’s Portfolio AVTX Stock Details AVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$66.7M Buy
+3,610,000
New +$57.1M 0.97% 35
2025
Q4 		– Sell
-144,600
Closed -$1.84M – 60
2025
Q3 		$1.84M Sell
144,600
-422,503
-75% -$3.63M 0.05% 53
2025
Q2 		$2.83M Sell
567,103
-292,773
-34% -$1.37M 0.09% 61
2025
Q1 		$6.89M Sell
859,876
-7,124
-0.8% -$54K 0.22% 53
2024
Q4 		$6.44M Sell
867,000
-100,000
-10% -$1.07M 0.24% 54
2024
Q3 		$9.19M Buy
+967,000
New +$9.97M 0.29% 58

Other funds holding AVTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Deep Track Capital's AVTX Position: Q2 2026 in Review

Deep Track Capital opened a new position in Avalo Therapeutics (AVTX) in Q2 2026: 3,610,000 shares worth $66.7M. The stake represents 0.97% of the portfolio and ranks #35 among its holdings. This is a return to the name: Deep Track Capital previously reported a position in AVTX as recently as Q3 2025.

Deep Track Capital first reported a position in AVTX in Q3 2024 and has held it in 6 quarters since. 126 funds tracked by Wall St. Rank hold AVTX as of Q2 2026.

  • Deep Track Capital held 3,610,000 shares of Avalo Therapeutics worth $66.7M as of Q2 2026.
  • Avalo Therapeutics was a new Deep Track Capital position in Q2 2026.
  • Avalo Therapeutics made up 0.97% of Deep Track Capital's portfolio in Q2 2026, its #35 holding.
  • Deep Track Capital first reported a position in Avalo Therapeutics in Q3 2024 and has held it in 6 quarters since.
  • 126 funds tracked by Wall St. Rank held Avalo Therapeutics as of Q2 2026.

Based on Deep Track Capital's 13F filing for Q2 2026, filed 14 Aug 2026.